Tisagenlecleucel (Kymriah) For Pediatric Patients Or Young Adult Patients Up To 25 Years Of Age

  Address - Finland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102351047

  Document Type - Tender Notices

Description - Description: Tisagenlecleucel (Kymriah 1.2x10e6-6x10e8 cells infusion solution) for use in accordance with the recommendation of the Finnish Health Care Service Selection Council (Palko) (13 March 2019) in the treatment of B-cell acute lymphoblastic leukemia (ALL) in pediatric patients and young adult patients up to 25 years of age when the disease has not responded to previous treatment (treatment-resistant), when it has relapsed two or more times, or when it has relapsed after stem cell transplantation.local title:: Tisagenlekleuseeli (Kymriah) lapsipotilaille tai korkeintaan 25 vuoden ikäisille nuorille aikauispotilailleContract Type: : Supplylocal description: : Tisagenlekleuseeli (Kymr

Gt Ref Id - 102351047

Deadline - Feb 12, 2025